Showing results (131-140 of 191) with videos related to
Sort By:
Pageof 20
Acta Oto-Laryngologica|October 11, 2021
OnabotulinumtoxinA injection towards the SPG for treating symptoms of refractory chronic rhinosinusitis with nasal polyposis: a pilot studyKent Are Jamtøy, Erling Tronvik, Daniel Fossum Bratbak, et al.Cephalalgia : an International Journal of Headache|June 1, 2018
Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trialVladimir Skljarevski, Manjit Matharu, Brian A Millen, et al.Neurology|October 15, 2017
Optimal deep brain stimulation site and target connectivity for chronic cluster headacheHarith Akram, Sarah Miller, Susie Lagrata, et al.BMJ Neurology Open|April 22, 2024
Adverse and serious adverse events incidence of pharmacological interventions for managing chronic and episodic migraine in adults: a systematic reviewSeyran Naghdi, Martin Underwood, Anna Brown, et al.Cephalalgia : an International Journal of Headache|May 8, 2016
Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraineDaniel Fossum Bratbak, Ståle Nordgård, Lars Jacob Stovner, et al.Cephalalgia : an International Journal of Headache|July 12, 2023
Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over studyKent A Jamtøy, Wenche M Thorstensen, Lars J Stovner, et al.Cephalalgia : an International Journal of Headache|December 6, 2016
Does pain sensitivity change by migraine phase? A blinded longitudinal studyMartin Uglem, Petter Moe Omland, Kristian Bernhard Nilsen, et al.Headache|May 6, 2024
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I studyDawn C Buse, Fumihiko Sakai, Manjit Matharu, et al.Headache|April 22, 2026
Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3-Month results from the TRIUMPH studyShivang Joshi, Cristina Tassorelli, Manjit Matharu, et al.Cephalalgia : an International Journal of Headache|August 21, 2024
Open label experience of repeated OnabotulinumtoxinA injections towards the sphenopalatine ganglion in patients with chronic cluster headache and chronic migraineLucy Simmonds, Kent Are Jamtøy, Irina Aschehoug, et al.Pageof 20